Canaccord Genuity Upgrades Repro Med Systems to Buy Rating From Hold, Adjusts Price Target to $4 From $3
Canaccord Genuity Upgrades Repro Med Systems to Buy Rating From Hold, Adjusts Price Target to $4 From $3
Canaccord Genuity 將 Repro Med Systems 的評級從持倉上調至買入，將目標價從 3 美元調整爲 4 美元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊